Toggle navigation
Home
Company directory
Life science ecosystem
A whole range of premises
Living and working
Team
Media
Accueil
»
Media
Media
Press releases
Download the press releases on SMO Biopôle Clermont-Limagne and its members.
Search
types de communiqués
SMO Biopôle Clermont-Limagne
Companies
Alphanosos
Aptys Pharma
Carbios
Carbogen Amcis
GIMRA
Greencell
Horée cosmétiques
Icare
Jacquet
Limagrain
METabolic EXplorer
Oncosema
Sabi Agri
SMO Biopôle Clermont-Limagne
Valbiotis
Végépolys Valley
25/03/2024
- METabolic EXplorer
Opening a safeguard procedure for METabolic EXplorer – Opening of a judicial restructuring for its subsidiary METEX NØVISTA (IN FRENCH).
21/03/2024
- METabolic EXplorer
METEX NØØVISTAGO initiates safeguard proceedings (IN FRENCH).
12/03/2024
- METabolic EXplorer
METabolic EXplorer sollicite l’ouverture d’une procédure de sauvegarde.
12/03/2024
- METabolic EXplorer
Suspension of trading in METEX shares.
28/02/2024
- Limagrain
Towards innovative, sustainable and resilient agriculture: INRAE and Limagrain committed to a new framework agreement (IN FRENCH).
15/02/2024
- METabolic EXplorer
Fourth quarter 2023 consolidated turnover (IN FRENCH)
18/01/2024
- Limagrain
Quiterie FOULET appointed Deputy Managing Director of Limagrain (IN FRENCH).
08/01/2024
- Aptys Pharma
APTYS Pharma appoints new R&D Director as new R&D Director
12/12/2023
- Valbiotis
Launch of a capital increase.
12/12/2023
- Valbiotis
Availability of an amendment to the 2022 Universal Registration Document.
12/12/2023
- Valbiotis
FDA approval for NDI status
12/12/2023
- METabolic EXplorer
Strategic transformation plan (IN FRENCH).
30/11/2023
- Alphanosos
Eurofragance and Alphanosos join forces to address malodors.
16/11/2023
- METabolic EXplorer
Appointment of Maria Wiltz as Director in charge of Group Business Development Strategy at METabolic EXplorer as part of its strategic transformation plan (IN FRENCH).
09/11/2023
- METabolic EXplorer
Rudolph Hidalgo appointed Deputy CEO of METabolic EXplorer Group as part of its strategic transformation plan (IN FRENCH).
09/11/2023
- METabolic EXplorer
Consolidated sales for the third quarter of 2022: €54.8 million (IN FRENCH).
03/10/2023
- Valbiotis
Valbiotis: the Phase II/III REVERSE-IT study selected for an oral presentation at the 2023 EASD congress, the main European learned society for diabetes.
29/09/2023
- METabolic EXplorer
2023 Semi-Annual Results (IN FRENCH).
28/09/2023
- Valbiotis
Valbiotis publishes its financial report for the first half of 2023 and confirms its strategic roadmap.
21/09/2023
- Végépolys Valley
“Accelerate your plant innovation!” VEGEPOLYS VALLEY launches the 8th edition of its contest dedicated to startups
« Previous
1
2
3
4
…
8
Next »
